These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 14991821)

  • 1. Readthrough of dystrophin stop codon mutations induced by aminoglycosides.
    Howard MT; Anderson CB; Fass U; Khatri S; Gesteland RF; Atkins JF; Flanigan KM
    Ann Neurol; 2004 Mar; 55(3):422-6. PubMed ID: 14991821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.
    Howard MT; Shirts BH; Petros LM; Flanigan KM; Gesteland RF; Atkins JF
    Ann Neurol; 2000 Aug; 48(2):164-9. PubMed ID: 10939566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system.
    Keeling KM; Bedwell DM
    J Mol Med (Berl); 2002 Jun; 80(6):367-76. PubMed ID: 12072912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.
    Malik V; Rodino-Klapac LR; Viollet L; Wall C; King W; Al-Dahhak R; Lewis S; Shilling CJ; Kota J; Serrano-Munuera C; Hayes J; Mahan JD; Campbell KJ; Banwell B; Dasouki M; Watts V; Sivakumar K; Bien-Willner R; Flanigan KM; Sahenk Z; Barohn RJ; Walker CM; Mendell JR
    Ann Neurol; 2010 Jun; 67(6):771-80. PubMed ID: 20517938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Readthrough strategies for stop codons in Duchenne muscular dystrophy.
    Aurino S; Nigro V
    Acta Myol; 2006 Jun; 25(1):5-12. PubMed ID: 17039975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations.
    Wagner KR; Hamed S; Hadley DW; Gropman AL; Burstein AH; Escolar DM; Hoffman EP; Fischbeck KH
    Ann Neurol; 2001 Jun; 49(6):706-11. PubMed ID: 11409421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy.
    Kimura S; Ito K; Miyagi T; Hiranuma T; Yoshioka K; Ozasa S; Matsukura M; Ikezawa M; Matsuo M; Takeshima Y; Miike T
    Brain Dev; 2005 Sep; 27(6):400-5. PubMed ID: 16122626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic readthrough strategy for suppression of nonsense mutations in duchenne muscular dystrophy].
    Shiozuka M; Matsuda R
    Brain Nerve; 2011 Nov; 63(11):1253-60. PubMed ID: 22068478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment.
    Bidou L; Hatin I; Perez N; Allamand V; Panthier JJ; Rousset JP
    Gene Ther; 2004 Apr; 11(7):619-27. PubMed ID: 14973546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycosides and other factors promoting stop codon readthrough in human cells.
    Diop D; Chauvin C; Jean-Jean O
    C R Biol; 2007 Jan; 330(1):71-9. PubMed ID: 17241950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer syndromes and therapy by stop-codon readthrough.
    Bordeira-Carriço R; Pêgo AP; Santos M; Oliveira C
    Trends Mol Med; 2012 Nov; 18(11):667-78. PubMed ID: 23044248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside treatment for muscular dystrophy is scientifically rational, but is it clinically effective?
    Hirano M
    Curr Neurol Neurosci Rep; 2002 Jan; 2(1):53-4. PubMed ID: 11898583
    [No Abstract]   [Full Text] [Related]  

  • 13. Translational readthrough induction of pathogenic nonsense mutations.
    Kellermayer R
    Eur J Med Genet; 2006; 49(6):445-50. PubMed ID: 16740421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Guanidino-quinazoline promotes the readthrough of nonsense mutations underlying human genetic diseases.
    Bidou L; Bugaud O; Merer G; Coupet M; Hatin I; Chirkin E; Karri S; Demais S; François P; Cintrat JC; Namy O
    Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2122004119. PubMed ID: 35994666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro.
    Popescu AC; Sidorova E; Zhang G; Eubanks JH
    J Neurosci Res; 2010 Aug; 88(11):2316-24. PubMed ID: 20623622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
    Nudelman I; Rebibo-Sabbah A; Cherniavsky M; Belakhov V; Hainrichson M; Chen F; Schacht J; Pilch DS; Ben-Yosef T; Baasov T
    J Med Chem; 2009 May; 52(9):2836-45. PubMed ID: 19309154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical therapies to recode nonsense mutations in inherited diseases.
    Lee HL; Dougherty JP
    Pharmacol Ther; 2012 Nov; 136(2):227-66. PubMed ID: 22820013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin.
    Floquet C; Hatin I; Rousset JP; Bidou L
    PLoS Genet; 2012; 8(3):e1002608. PubMed ID: 22479203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential.
    Friesen WJ; Johnson B; Sierra J; Zhuo J; Vazirani P; Xue X; Tomizawa Y; Baiazitov R; Morrill C; Ren H; Babu S; Moon YC; Branstrom A; Mollin A; Hedrick J; Sheedy J; Elfring G; Weetall M; Colacino JM; Welch EM; Peltz SW
    PLoS One; 2018; 13(10):e0206158. PubMed ID: 30359426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of a readthrough-inducing drug: a new approach of gentamicin administration for the treatment of nonsense mutation-mediated disorders.
    Shiozuka M; Wagatsuma A; Kawamoto T; Sasaki H; Shimada K; Takahashi Y; Nonomura Y; Matsuda R
    J Biochem; 2010 Apr; 147(4):463-70. PubMed ID: 19910311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.